✦ LIBER ✦

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A phase II study of the eortc malignant melanoma cooperative group

✍ Scribed by C. F. Verschraegen; U. R. Kleeberg; J. Mulder; P. Rumke; F. Truchetet; B. Czarnetzki; M. Rozencweig; D. Thomas; S. Suciu

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 503 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880915)62:6<1061::aid-cncr2820620607>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PALA, vindesine, and cisplatin combinati

PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study

✍ Holger Voigt; Ulrich R. Kleeberg 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

A phase II study of dacarbazine and cisp

A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma

✍ Lawrence E. Flaherty; Bruce G. Redman; Silvana Martino; Michael Kraut; Manuel Va 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

A phase I-II study of dacarbazine in com

A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma

✍ Lawrence E. Flaherty; Bruce G. Redman; Guy G. Chabot; Silvana Martino; Steven M. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

Interferon in combination with vinblasti

Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study

✍ Stein Gundersen; A. Flokkmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol

The use of BELD combination chemotherapy

The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma

✍ David W. Young; Rosemary S. Lever; JOHN S. C. English; Rona M. Mackie 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views